BIRC5 and neoplasm: For example, polyclonal T cells reactive to 5 tumor-associated antigens—PRAME, SSX2, MAGEA4, SURVIVIN, and NY-ESO-1—were evaluated in 32 lymphoma patients (NCT01333046).